UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 82

Sortiert nach

Exogenous GDF11 induces cardiac and skeletal muscle dysfunction and wasting

Basic research in cardiology, 2017-07, Vol.112 (4), Article 48

2017

Link zum Volltext

Verfügbarkeit prüfen

Preservation of muscle mass as a strategy to reduce the toxic effects of cancer chemotherapy on body composition

Current opinion in supportive & palliative care, 2018-12, Vol.12 (4), p.420

2018

Link zum Volltext

Verfügbarkeit prüfen

Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism

Journal of cachexia, sarcopenia and muscle, 2019-02, Vol.10 (1), p.140-154

2019

Link zum Volltext

Verfügbarkeit prüfen

PDK4 drives metabolic alterations and muscle atrophy in cancer cachexia

The FASEB journal, 2019-06, Vol.33 (6), p.7778-7790

2019

Link zum Volltext

Verfügbarkeit prüfen

Gender differences in academic surgery, work-life balance, and satisfaction

The Journal of surgical research, 2017-10, Vol.218, p.99-107

2017

Link zum Volltext

Verfügbarkeit prüfen

Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia

Journal of cachexia, sarcopenia and muscle, 2018-08, Vol.9 (4), p.685-700

2018

Link zum Volltext

Verfügbarkeit prüfen

Three cachexia phenotypes and the impact of fat‐only loss on survival in FOLFIRINOX therapy for pancreatic cancer

Journal of cachexia, sarcopenia and muscle, 2018-08, Vol.9 (4), p.673-684

2018

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy-induced muscle wasting: association with NF-κB and cancer cachexia

European journal of translational myology, 2018-06, Vol.28 (2), p.7590-7590

2018

Link zum Volltext

Verfügbarkeit prüfen

Effect of Weight Loss on Short-Term Outcomes and Costs of Care After Head and Neck Cancer Surgery

Annals of otology, rhinology & laryngology, 2014-02, Vol.123 (2), p.101-110

2014

Link zum Volltext

Verfügbarkeit prüfen

The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy

Journal of cachexia, sarcopenia and muscle, 2019-10, Vol.10 (5), p.1083-1101

2019

Link zum Volltext

Verfügbarkeit prüfen

Skeletal muscle fiber size and fiber type distribution in human cancer: Effects of weight loss and relationship to physical function

Clinical nutrition (Edinburgh, Scotland), 2016-12, Vol.35 (6), p.1359-1365

2016

Link zum Volltext

Verfügbarkeit prüfen

Cancer cachexia update in head and neck cancer: Definitions and diagnostic features

Head & neck, 2015-04, Vol.37 (4), p.594-604

2015

Link zum Volltext

Verfügbarkeit prüfen

Oral Resveratrol Therapy Inhibits Cancer-Induced Skeletal Muscle and Cardiac Atrophy In Vivo

Nutrition and cancer, 2011-07, Vol.63 (5), p.749-762

2011

Link zum Volltext

Verfügbarkeit prüfen

Treatment with Soluble Activin Receptor Type IIB Alters Metabolic Response in Chemotherapy-Induced Cachexia

Cancers, 2019-08, Vol.11 (9), p.1222

2019

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of a combined antegrade and retrograde approach for dilatation of radiation-induced esophageal strictures (with video)

Gastrointestinal endoscopy, 2010-06, Vol.71 (7), p.1122-1129

2010

Link zum Volltext

Verfügbarkeit prüfen

Metabolic Biomarkers for the Early Detection of Cancer Cachexia

Frontiers in cell and developmental biology, 2021-09, Vol.9, p.720096-720096

2021

Link zum Volltext

Verfügbarkeit prüfen

Molecular biology of head and neck cancer: risks and pathways

Hematology/oncology clinics of North America, 2008-12, Vol.22 (6), p.1099

2008

Link zum Volltext

Verfügbarkeit prüfen

Defining Cancer Cachexia in Head and Neck Squamous Cell Carcinoma

Clinical cancer research, 2007-11, Vol.13 (22), p.6561-6567

2007

Link zum Volltext

Verfügbarkeit prüfen

Exogenous GDF11 induces cardiac and skeletal muscle dysfunction and wasting

Basic research in cardiology, 2017-07, Vol.112 (4), p.48-48

2017

Link zum Volltext

Verfügbarkeit prüfen

ACVR2B/Fc counteracts chemotherapy-induced loss of muscle and bone mass

Scientific reports, 2017-10, Vol.7 (1), p.14470-13, Article 14470

2017

Link zum Volltext

Verfügbarkeit prüfen

Use, Accuracy, and Implications for Patient Management of [18F]-2-Fluorodeoxyglucose-Positron Emission/Computerized Tomography for Head and Neck Tumors

The Laryngoscope, 2005-07, Vol.115 (7), p.1186-1190

2005

Link zum Volltext

Verfügbarkeit prüfen

Association of p16(INK4a) overexpression with improved outcomes in young patients with squamous cell cancers of the oral tongue

Head & neck, 2011-11, Vol.33 (11), p.1622-1627

2011

Link zum Volltext

Verfügbarkeit prüfen

Never-smokers, never-drinkers: Unique clinical subgroup of young patients with head and neck squamous cell cancers

Head & neck, 2010-04, Vol.32 (4), p.499-503

2010

Link zum Volltext

Verfügbarkeit prüfen

Alteration of Cellular and Humoral Immunity by Mutant p53 Protein and Processed Mutant Peptide in Head and Neck Cancer

Clinical cancer research, 2007-12, Vol.13 (23), p.7199-7206

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(71)

Publikationsform

Artikel
(82)

Sprache

Englisch
(82)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Exogenous GDF11 induces cardiac and skeletal muscle dysfunction and wasting

Preservation of muscle mass as a strategy to reduce the toxic effects of cancer chemotherapy on body composition

Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism

PDK4 drives metabolic alterations and muscle atrophy in cancer cachexia

Gender differences in academic surgery, work-life balance, and satisfaction

Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia

Three cachexia phenotypes and the impact of fat‐only loss on survival in FOLFIRINOX therapy for pancreatic cancer

Chemotherapy-induced muscle wasting: association with NF-κB and cancer cachexia

Effect of Weight Loss on Short-Term Outcomes and Costs of Care After Head and Neck Cancer Surgery

The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy

Skeletal muscle fiber size and fiber type distribution in human cancer: Effects of weight loss and relationship to physical function

Cancer cachexia update in head and neck cancer: Definitions and diagnostic features

Oral Resveratrol Therapy Inhibits Cancer-Induced Skeletal Muscle and Cardiac Atrophy In Vivo

Treatment with Soluble Activin Receptor Type IIB Alters Metabolic Response in Chemotherapy-Induced Cachexia

Outcomes of a combined antegrade and retrograde approach for dilatation of radiation-induced esophageal strictures (with video)

Metabolic Biomarkers for the Early Detection of Cancer Cachexia

Profiling of Adipose and Skeletal Muscle in Human Pancreatic Cancer Cachexia Reveals Distinct Gene Profiles with Convergent Pathways

Molecular biology of head and neck cancer: risks and pathways

Defining Cancer Cachexia in Head and Neck Squamous Cell Carcinoma

Exogenous GDF11 induces cardiac and skeletal muscle dysfunction and wasting

ACVR2B/Fc counteracts chemotherapy-induced loss of muscle and bone mass

Use, Accuracy, and Implications for Patient Management of [18F]-2-Fluorodeoxyglucose-Positron Emission/Computerized Tomography for Head and Neck Tumors

Association of p16(INK4a) overexpression with improved outcomes in young patients with squamous cell cancers of the oral tongue

Never-smokers, never-drinkers: Unique clinical subgroup of young patients with head and neck squamous cell cancers

Alteration of Cellular and Humoral Immunity by Mutant p53 Protein and Processed Mutant Peptide in Head and Neck Cancer

Suchergebnisse filtern